These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2409873)

  • 21. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
    Veith R; Galanello R; Papayannopoulou T; Stamatoyannopoulos G
    N Engl J Med; 1985 Dec; 313(25):1571-5. PubMed ID: 2415821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease.
    Atweh GF; Schechter AN
    Curr Opin Hematol; 2001 Mar; 8(2):123-30. PubMed ID: 11224687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experience.
    Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW
    Prog Clin Biol Res; 1989; 316B():281-93. PubMed ID: 2482498
    [No Abstract]   [Full Text] [Related]  

  • 24. Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease.
    Dover GJ; Charache S
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):61-6. PubMed ID: 1379374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia.
    Koshy M; Dorn L; Bressler L; Molokie R; Lavelle D; Talischy N; Hoffman R; van Overveld W; DeSimone J
    Blood; 2000 Oct; 96(7):2379-84. PubMed ID: 11001887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
    Yang YM; Pace B
    Pediatr Pathol Mol Med; 2001; 20(1):87-106. PubMed ID: 12673846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fetal hemoglobin].
    Rokicka-Piotrowicz M
    Postepy Hig Med Dosw; 1989; 43(5-6):475-97. PubMed ID: 2484927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells.
    Moutouh-de Parseval LA; Verhelle D; Glezer E; Jensen-Pergakes K; Ferguson GD; Corral LG; Morris CL; Muller G; Brady H; Chan K
    J Clin Invest; 2008 Jan; 118(1):248-58. PubMed ID: 18064299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Globin gene studies create a puzzle.
    Kolata G
    Science; 1984 Feb; 223(4635):470-1. PubMed ID: 6197757
    [No Abstract]   [Full Text] [Related]  

  • 30. Hydroxyurea therapy in thalassemia.
    Loukopoulos D; Voskaridou E; Stamoulakatou A; Papassotiriou Y; Kalotychou V; Loutradi A; Cozma G; Tsiarta H; Pavlides N
    Ann N Y Acad Sci; 1998 Jun; 850():120-8. PubMed ID: 9668534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlling the fetal globin switch in man.
    Orkin SH
    Nature; 1983 Jan; 301(5896):108-9. PubMed ID: 6185847
    [No Abstract]   [Full Text] [Related]  

  • 32. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.
    Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1990 Apr; 322(15):1037-45. PubMed ID: 1690857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing fetal hemoglobin production in sickle cell disease: results of clinical trials.
    Dover GJ; Charache S
    Prog Clin Biol Res; 1987; 251():455-66. PubMed ID: 2448813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of fetal hemoglobin synthesis in the hemoglobinopathies.
    Nathan DG
    Ann N Y Acad Sci; 1985; 445():177-87. PubMed ID: 2409870
    [No Abstract]   [Full Text] [Related]  

  • 35. Sickle cell paths converge on hydroxyurea.
    Platt OS
    Nat Med; 1995 Apr; 1(4):307-8. PubMed ID: 7585059
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia.
    Musallam KM; Taher AT; Cappellini MD; Sankaran VG
    Blood; 2013 Mar; 121(12):2199-212; quiz 2372. PubMed ID: 23315167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approaches to the reactivation of hemoglobin F as a treatment for sickle cell disease.
    DeSimone J
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):23-4. PubMed ID: 16163154
    [No Abstract]   [Full Text] [Related]  

  • 38. The biophysics of sickle cell hydroxyurea therapy.
    Eaton WA; Hofrichter J
    Science; 1995 May; 268(5214):1142-3. PubMed ID: 7539154
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacologic manipulation of fetal hemoglobin synthesis.
    Dover GJ; Humphries RK; Young N; Ley T; Boyer S; Charache S; Nienhuis A
    Prog Clin Biol Res; 1985; 191():447-54. PubMed ID: 2413480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia.
    Charache S; Dover GJ; Moyer MA; Moore JW
    Blood; 1987 Jan; 69(1):109-16. PubMed ID: 2431728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.